Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

SHA:600223 Revenue

Lushang Freda Pharmaceutical had revenue of 900.44M CNY in the quarter ending March 31, 2026, with 2.78% growth. This brings the company's revenue in the last twelve months to 3.68B, down -7.38% year-over-year. In the year 2025, Lushang Freda Pharmaceutical had annual revenue of 3.65B, down -8.33%.

• Revenue (ttm): 3.68B
• Revenue Growth: -7.38%
• P/S Ratio: 1.75
• Revenue / Employee: 1.05M
• Employees: 3,514
• Market Cap: 6.43B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.65B	-331.68M	-8.33%
Dec 31, 2024	3.98B	-596.17M	-13.02%
Dec 31, 2023	4.58B	-8.37B	-64.65%
Dec 31, 2022	12.95B	588.17M	4.76%
Dec 31, 2021	12.36B	-1.25B	-9.20%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error